Share
Journal Information
Issue
Vol. 18. Issue 2.Pages 279-408 (March - April 2019)
Editorial
Regeneration of Annals of Hepatology: Renewed, active and growing stronger
Arturo Panduro
Ann Hepatol. 2019;18:279-80
Open access
Viewpoints
Consensus and clinical practice guidelines in Latin America: Who, where, when and how
Octavio Campollo, Sonia Roman
Ann Hepatol. 2019;18:281-4
Open access
Human immunodeficiency virus and the liver: The impact of coinfection with hepatotropic viruses
Leonor Huerta, Julio Y. Anaya-Covarrubias, Nora A. Fierro
Ann Hepatol. 2019;18:285-6
Open access
Concise reviews
Vasoconstrictors in hepatorenal syndrome – A critical review
Ângelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos
Ann Hepatol. 2019;18:287-90
Open access
Immunotherapy in hepatocellular carcinoma
Luigi Buonaguro, Angela Mauriello, Beatrice Cavalluzzo, Annacarmen Petrizzo, Maria Tagliamonte
Ann Hepatol. 2019;18:291-7
Open access
Original article
Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population
Yaru Li, Jing Wang, Xu Han, Hua Hu, Fei Wang, Caizheng Yu, Jing Yuan, Ping Yao, ... Meian He
Ann Hepatol. 2019;18:298-303
Open access
Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic
Miguel Malespin, Ciel Harris, Ozdemir Kanar, Kelly Jackman, Carmen Smotherman, Abbey Johnston, Julie Ferm, Silvio W. de Melo, ... Scott J. Cotler
Ann Hepatol. 2019;18:304-9
Open access
A validated risk model for prediction of early readmission in patients with hepatic encephalopathy
Andrew J. Kruger, Fasika Aberra, Sylvester M. Black, Alice Hinton, James Hanje, Lanla F. Conteh, Anthony J. Michaels, Somashekar G. Krishna, Khalid Mumtaz
Ann Hepatol. 2019;18:310-7
Open access
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance
Massimo Iavarone, Mauro Viganò, Nicole Piazza, Vincenzo Occhipinti, Angelo Sangiovanni, Marco Maggioni, Gioacchino D’Ambrosio, Laura V. Forzenigo, ... Massimo Colombo
Ann Hepatol. 2019;18:318-24
Open access
Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.
Luis A. Díaz, Blanca Norero, Bárbara Lara, Camila Robles, Susana Elgueta, Roberto Humeres, Jaime Poniachik, Guillermo Silva, ... Rosa M. Pérez
Ann Hepatol. 2019;18:325-30
Open access
Serial assessment of hepatic encephalopathy in patients hospitalised for acute decompensation of cirrhosis
Dariana C. Maggi, Ariane Borgonovo, Emília T. Bansho, Pedro E. Soares-Silva, Telma E. Silva, Bruno S. Colombo, Letícia M. Wildner, Maria L. Bazzo, ... Leonardo L. Schiavon
Ann Hepatol. 2019;18:331-7
Open access
Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry
Manuel Mendizabal, Viviana Tagliafichi, Fernando Rubinstein, Paloma Rojas, Sebastían Marciano, Silvina Yantorno, Nora Cejas, Martín Barrabino, ... Marcelo O. Silva
Ann Hepatol. 2019;18:338-44
Open access
Changes in amino acid profiles and liver alterations in pregnant rats with a high carbohydrate/low protein diet
Mónica Navarro-Meza, Ana B. Cardador-Martínez, Olivia Vazquez-Martínez, José A. Cruz-Ramos, Felipe Santoyo-Telles, Jesús A. Bejarano-Carrillo, Arianna J. Manzano-Hernández, Mauricio Díaz-Muñoz
Ann Hepatol. 2019;18:345-53
Open access
Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes
James C. Barton, J. Clayborn Barton, Paul C. Adams
Ann Hepatol. 2019;18:354-9
Open access
Epidemiologic features of a large hepatitis C cohort evaluated in a major health system in the western United States
Nizar A. Mukhtar, Erik M. Ness, Manan Jhaveri, Oren K. Fix, Marquis Hart, Christopher Dale, Cheryl Pratt, Kris V. Kowdley
Ann Hepatol. 2019;18:360-5
Open access
Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis
Virginia Gonzalez-Polo, Melisa Pucci-Molineris, Victorio Cervera, Sabrina Gambaro, Silvina E. Yantorno, Valeria Descalzi, Claudio Tiribelli, Gabriel E. Gondolesi, Dominik Meier
Ann Hepatol. 2019;18:366-72
Open access
Acute-on-chronic liver failure: A comparison of three different diagnostic criteria
Gabriel S. Leão, Felipe L. Lunardi, Rafael V. Picon, Cristiane V. Tovo, Angelo A. de Mattos, Ângelo Z. de Mattos
Ann Hepatol. 2019;18:373-8
Open access
Association between plasma bilirubin and mortality
Libor Vitek, Jaroslav A. Hubacek, Andrzej Pajak, Agnieszka Doryńska, Magdalena Kozela, Lenka Eremiasova, Vilem Danzig, Denes Stefler, Martin Bobak
Ann Hepatol. 2019;18:379-85
Open access
Accuracy of the BAR score in the prediction of survival after liver transplantation
Jorge A. Martínez, Sergio Pacheco, Jean P. Bachler, Nicolás Jarufe, Eduardo Briceño, Juan F. Guerra, Carlos Benítez, Rodrigo Wolff, ... Marco Arrese
Ann Hepatol. 2019;18:386-92
Open access
Case report
Plasma transfusion combined with chelating therapy alleviates fulminant Wilson's disease with a single Arg778Leu heterozygote mutation
Longgen Liu, Qing Gong, Juan Liu, Hongyu Shen, Hongyu Zhang, Yuan Xue
Ann Hepatol. 2019;18:393-6
Open access
Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation
Taiga Wakabayashi, Hideaki Obara, Morinobu Seki, Masahiro Shinoda, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Kentaro Matsubara, ... Yuko Kitagawa
Ann Hepatol. 2019;18:397-401
Open access
News
Correspondence
Cerebral autoregulation in a fulminant hepatic failure patient who underwent liver transplantation
Fernando M. Paschoal-Jr, Ricardo C. Nogueira, Marcelo de-Lima-Oliveira, Eric H. Paschoal, Manoel J. Teixeira, Luiz A. D’Albuquerque, Edson Bor-Seng-Shu
Ann Hepatol. 2019;18:403-4
Open access
No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma
Ngo Tat Trung, Le Trung Hai, Dao Phuong Giang, Phan Quoc Hoan, Mai Thanh Binh, Nghiem Xuan Hoan, Nguyen Linh Toan, Christian G. Meyer, ... Le Huu Song
Ann Hepatol. 2019;18:404-5
Open access
RUCAM-based assessment of liver injury by xiang-tian-guo (Swietenia macrophylla) seeds, a plant used for treatment of hypertension and diabetes
Youwen Tan, Hongbo Chen, Xinbei Zhou, Li Sun
Ann Hepatol. 2019;18:406-7
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
